Kazunobu Sawamoto Selected Research

Kazunobu Sawamoto Research Topics

Disease

6	Brain Ischemia (Cerebral Ischemia) 09/2011 - 06/2005
5	Stroke (Strokes) 11/2021 - 09/2007
4	Neoplasms (Cancer) 01/2020 - 10/2009
3	Brain Injuries (Brain Injury) 02/2013 - 06/2005
3	Ischemia 09/2011 - 09/2005
3	Infarction (Infarctions) 04/2010 - 06/2005
3	Alzheimer Disease (Alzheimer's Disease) 04/2008 - 10/2006
3	Parkinson Disease (Parkinson's Disease) 09/2007 - 10/2002
2	Hepatitis 01/2020 - 01/2015
2	Schizophrenia (Dementia Praecox) 06/2011 - 09/2009
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 07/2005 - 06/2005
1	Hydrocephalus (Hydrocephaly) 01/2021
1	Neurodevelopmental Disorders 01/2021
1	Body Weight (Weight, Body) 01/2020
1	Obesity 01/2020
1	Sick Building Syndrome 08/2016
1	Chronic Hepatitis C 01/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2011
1	Hypoxia (Hypoxemia) 10/2011
1	Brain Diseases (Brain Disorder) 11/2009
1	Brain Neoplasms (Brain Tumor) 10/2009
1	Seizures (Absence Seizure) 03/2009
1	Spinal Cord Injuries (Spinal Cord Injury) 09/2007
1	Cognitive Dysfunction 10/2006
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2006
1	Down Syndrome (Down's Syndrome) 01/2006
1	Chromosomal Instability (Chromosome Stability) 02/2002

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2005
4	CytokinesIBA 01/2020 - 06/2005
3	Donepezil (Aricept)FDA LinkGeneric 04/2008 - 10/2006
3	Cholinesterase Inhibitors (Anticholinesterases)IBA 04/2008 - 10/2006
2	Therapeutic UsesIBA 11/2021 - 02/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2021 - 06/2017
2	Interferon-alpha (Interferon Alfa)IBA 01/2020 - 01/2015
2	Erythropoietin FDA Link 10/2012 - 10/2011
2	NestinIBA 04/2010 - 09/2005
1	HydrogelsIBA 11/2021
1	Peptides (Polypeptides)IBA 11/2021
1	Proteoglycans (Proteoglycan)IBA 01/2021
1	Nicotine FDA Link 01/2020
1	EndocannabinoidsIBA 01/2020
1	ChromatinIBA 11/2017
1	IntegrinsIBA 02/2017
1	2-ethylhexanolIBA 08/2016
1	InterferonsIBA 01/2016
1	Antiviral Agents (Antivirals)IBA 01/2015
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2012
1	Neuroprotective AgentsIBA 10/2011
1	Galectin 1 (LGALS1)IBA 09/2011
1	LectinsIBA 09/2011
1	Glial Fibrillary Acidic ProteinIBA 04/2010
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 04/2010
1	Cyclin-Dependent Kinase Inhibitor p16IBA 10/2009
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2009
1	Pentylenetetrazole (Metrazol)IBA 03/2009
1	Acetylcholine (Acetylcholine Chloride)FDA Link 10/2006
1	ErbB Receptors (EGF Receptor)IBA 07/2006
1	Cell Adhesion MoleculesIBA 01/2006
1	Protein Isoforms (Isoforms)IBA 01/2006
1	AntibodiesIBA 01/2006
1	Transcription Factors (Transcription Factor)IBA 09/2005
1	Indicators and Reagents (Reagents)IBA 09/2005
1	TubulinIBA 09/2005
1	DNA (Deoxyribonucleic Acid)IBA 09/2005
1	Bromodeoxyuridine (BrdU)IBA 09/2005
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 07/2005
1	Monoclonal AntibodiesIBA 07/2005
1	Interleukin-6 (Interleukin 6)IBA 07/2005
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 07/2005
1	InterleukinsIBA 07/2005
1	Phosphates (Orthophosphate)IBA 06/2005
1	OSM-LIF ReceptorsIBA 06/2005
1	salicylhydroxamic acid (SHAM)IBA 06/2005
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 02/2002

Therapy/Procedure

6	Therapeutics 01/2021 - 10/2002
3	Transplantation 09/2011 - 10/2002
1	Cell Transplantation 11/2021
1	Microspheres (Microsphere) 01/2012